MLC1 and infection: Our findings show that pre-treatment of macrophages with Sn-specific antibodies or nanobodies partially abrogates the IFN-α induced effects resulting in a lower infection index 48 h post-infection with the different VL strains (SySy94: p = 0.0037; Biv4.40: p = 0.0053).